Residual host cell DNA is a critical quality control parameter in the production of biologics, especially those derived from E. coli expression systems. Excessive levels of host DNA may pose safety...

Mycoplasma contamination is a critical issue in the biopharmaceutical industry, warranting stringent prevention and control measures. Contamination can result in abnormal cell cultures, compromise...